Renal function and symptoms/adverse effects in opioid-treated patients with cancer (Q41760447)

9 October 2017

Renal function and symptoms/adverse effects in opioid-treated patients with cancer (English)

1 reference

9 October 2017

Lona Louring Christrup

5

1 reference

9 October 2017

8

P Klepstad

1 reference

9 October 2017

7

S Kaasa

1 reference

9 October 2017

9

O Dale

1 reference

9 October 2017

G P Kurita

1

1 reference

9 October 2017

S Lundström

2

1 reference

9 October 2017

P Sjøgren

3

1 reference

9 October 2017

O Ekholm

4

1 reference

9 October 2017

A Davies

6

1 reference

9 October 2017

language of work or name

English

0 references

publication date

5 May 2015

1 reference

Acta Anaesthesiologica Scandinavica

9 October 2017

1 reference

9 October 2017

59

1 reference

9 October 2017

8

1 reference

9 October 2017

1049-1059

1 reference

Identifying patients with chronic kidney disease from general practice computer records

9 October 2017

1 reference

Influences on the pharmacokinetics of oxycodone: a multicentre cross-sectional study in 439 adult cancer patients

21 January 2018

1 reference

A systematic review of the use of opioid medication for those with moderate to severe cancer pain and renal impairment: a European Palliative Care Research Collaborative opioid guidelines project.

21 January 2018

1 reference

Variability in UDP-glucuronosyltransferase genes and morphine metabolism: observations from a cross-sectional multicenter study in advanced cancer patients with pain

21 January 2018

1 reference

Opioids in renal failure and dialysis patients

21 January 2018

1 reference

Influence from genetic variability on opioid use for cancer pain: a European genetic association study of 2294 cancer pain patients

21 January 2018

1 reference

Is oxycodone efficacy reflected in serum concentrations? A multicenter, cross-sectional study in 456 adult cancer patients

21 January 2018

1 reference

The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology

21 January 2018

1 reference

Self-assessment in cancer patients referred to palliative care: a study of feasibility and symptom epidemiology

21 January 2018

1 reference

21 January 2018

1 reference

Predicting GFR in children and adults: a comparison of the Cockcroft-Gault, Schwartz, and modification of diet in renal disease formulas

21 January 2018

1 reference

An alternative formula to the Cockcroft-Gault and the modification of diet in renal diseases formulas in predicting GFR in individuals with type 1 diabetes

21 January 2018

1 reference

Application issues in bioanalytical method validation, sample analysis and data reporting

21 January 2018

1 reference

Early pharmacokinetics of nasal fentanyl: is there a significant arterio-venous difference?

21 January 2018

1 reference

A double-blind, randomized, crossover comparison between single-dose and double-dose immediate-release oral morphine at bedtime in cancer patients

21 January 2018

1 reference

Use of opioid analgesics in the treatment of cancer pain: evidence-based recommendations from the EAPC.

21 January 2018

1 reference

Estimating glomerular filtration rate: Cockcroft-Gault and Modification of Diet in Renal Disease formulas compared to renal inulin clearance

21 January 2018

1 reference

Methods to evaluate renal function in elderly patients: a systematic literature review.

21 January 2018

1 reference

Opioid use in cancer pain. Is a more liberal approach enhancing toxicity?

21 January 2018

1 reference

Pharmacological consequences of long-term morphine treatment in patients with cancer and chronic non-malignant pain

21 January 2018

1 reference

Is development of hyperalgesia, allodynia and myoclonus related to morphine metabolism during long-term administration? Six case histories

21 January 2018

1 reference

Plasma concentrations and renal clearance of morphine, morphine-3-glucuronide and morphine-6-glucuronide in cancer patients receiving morphine

21 January 2018

1 reference

The use of major analgesics in patients with renal dysfunction.

21 January 2018

1 reference

Prevalence of Renal Insufficiency in cancer patients and implications for anticancer drug management

21 January 2018

1 reference

Analytical methods validation: Bioavailability, bioequivalence and pharmacokinetic studies

21 January 2018

1 reference

Low-level quantitation of oxycodone and its oxidative metabolites, noroxycodone, and oxymorphone, in rat plasma by high-performance liquid chromatography–electrospray ionization–tandem mass spectrometry

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/AAS.12521

1 reference

9 October 2017

1 reference